Jasper Therapeutics Inc logo

Jasper Therapeutics Inc

$ 2.10 -0.16 (-7.08%) 03:59 PM EST
P/E:
At Loss
P/B:
1.18
Market Cap:
$ 79.54M
Enterprise V:
$ 19.10M
Volume:
49.68K
Avg Vol (2M):
44.76K
Volume:
49.68K
Market Cap $:
79.54M
PE Ratio:
At Loss
Avg Vol (2-Month):
44.76K
Enterprise Value $:
19.10M
PB Ratio:
1.18
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Jasper Therapeutics Inc
NAICS : 325412 SIC : 2834
2200 Bridge Parkway, Suite No. 102, Redwood, CA, USA, 94065
Description
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Name Current Vs Industry Vs History
Cash-To-Debt 18.03
Equity-to-Asset 0.85
Debt-to-Equity 0.06
Debt-to-EBITDA -0.13
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 70.87
9-Day RSI 62.67
14-Day RSI 56.03
6-1 Month Momentum % -49.45

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.36
Quick Ratio 12.36
Cash Ratio 11.79

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-15 Est.)

JSPR's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:JSPR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.989
Beta 0
Volatility % 0
14-Day RSI 56.03
14-Day ATR ($) 0.221932
20-Day SMA ($) 2.05375
12-1 Month Momentum % 0
52-Week Range ($) 1.73 - 18.88
Shares Outstanding (Mil) 37.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Jasper Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More